Viozan

Libraries of dibasic compounds designed around the molecular scaffold of the DA(2)/β(2) dual agonist sibenadet (Viozan™) have… Expand

Starting with the molecular scaffold of the DA(2)/β(2) dual agonist sibenadet (Viozan™), a number of molecular changes were… Expand

Viozan TM (sibenadet HCI,AR-C68397AA) is a novel dual D 2 dopamine receptor, 132-adrenoceptor agonist that has been investigated… Expand

1. Sibenadet (Viozan), a dual dopamine D(2)/beta(2)-adrenoceptor agonist, suppresses histamine-induced tachypnoea in the dog by… Expand

Viozan (sibenadet HCl, AR-C68397AA) is a novel dual D2 dopamine receptor, beta2-adrenoceptor agonist, developed specifically to… Expand

Viozan, (Sibenadet HCl, AR-C68397AA) is a dual D2 dopamine receptor, beta2-adrenoceptor agonist that combines bronchodilator… Expand

Viozan (sibenadet HCl, AR-C68397AA) is a novel dual D2 dopamine receptor, beta2-adrenoceptor agonist that has been investigated… Expand

The development of novel drugs for the treatment of chronic obstructive pulmonary disease (COPD) poses significant challenges… Expand

Sensory nerves regulate central and local reflexes such as airway plasma leakage, and cough and their function may be enhanced… Expand

Abstract. The mechanism by which 2(3H)-benzothiazolone, 4-hydroxy-7-[2-[[2-[[3-(2-phenylethoxy)propyl]sulphonyl]ethyl]amino]ethyl… Expand